allopurinol
FDA Approved, EMA Approved
Description
Allopurinol is a xanthine oxidase inhibitor that reduces uric acid production. It is used to manage hyperuricemia in various conditions including autosomal dominant medullary cystic kidney disease with hyperuricemia. The drug prevents complications of chronic uric acid elevation.
Indications & Therapeutic Use
gout, hyperuricemia, kidney stones, medullary cystic kidney disease with hyperuricemia
Global Availability (11 countries)
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
allopurinol
| Generic Name | allopurinol |
| Brands | 1 brand available |
| Active Ingredient | allopurinol |
| Drug Class | gout |
| Manufacturer | GlaxoSmithKline |
| Dosage Forms | Oral tablet, 100mg, 300mg |
| Medical Code | M04AA01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 2 days |
| Reg. Status | FDA Approved, EMA Approved |
| Countries | 11 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations12 Validated Nodes